Belimumab Impacting Transplant Eligibility
Clinical trial NCT02500251 · COMPLETED
Trial details
- NCT number
- NCT02500251
- Sponsor
- E. Steve Woodle
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.